August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.